Herantis Pharma Plc completes patient treatments in main study of Phase 1-2 CDNF trial in Parkinson’s disease

EPDA European projects – TreatER

Renishaw’s neuroinfuseTM drug delivery system shortlisted for Healthcare Award

Trials on track as CDNF readout nears

Prof. Mart Saarma – Unconventional Endoplasmic Reticulum Located Trophic Factor for Parkinson’s Disease

Novel drug delivered direct to brain may halt Parkinson’s

H2020 funding for clinical development – case Herantis Pharma